Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
Karuna Therapeutics, Inc. has filed 460 SEC EDGAR filings since 29 Mar 2019

SEC filing history

Showing 301-325 of 460 matching filings.

Per page
25
Current page
13
4

FORM 4 SUBMISSION

Filing date
22 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
22 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
22 Dec 2020
Reporting date
22 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Dec 2020
Reporting date
10 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
14 Dec 2020
Reporting date
14 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
03 Dec 2020
Reporting date
03 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3 SUBMISSION

Filing date
03 Dec 2020
Reporting date
03 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
03 Dec 2020
Reporting date
03 Dec 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES

Filing date
16 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Nov 2020
Reporting date
10 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
12 Nov 2020
Reporting date
12 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Nov 2020
Reporting date
06 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
10-Q File 001-38958

KRTX-10-Q-20200930

Filing date
05 Nov 2020
Reporting date
30 Sep 2020
Next action
Verify source filing
8-K File 001-38958

FORM 8-K

Filing date
05 Nov 2020
Reporting date
05 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
03 Nov 2020
Reporting date
03 Nov 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
13 Oct 2020
Reporting date
13 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
13 Oct 2020
Reporting date
12 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-38958

8-K

Filing date
07 Oct 2020
Reporting date
07 Oct 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
18 Sep 2020
Reporting date
16 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

OWNERSHIP DOCUMENT

Filing date
11 Sep 2020
Reporting date
09 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Sep 2020
Reporting date
10 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

PRIMARY DOCUMENT

Filing date
10 Sep 2020
Reporting date
08 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
09 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Sep 2020
Reporting date
04 Sep 2020
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .